Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 2,5 % øjendråber til engangsbrug |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 10 % øjendråber til engangsbrug |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 50 mg/g eye drops |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 10 % øjendråber uden konserveringsmiddel |
Is a |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride [CVS sympathomimetic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine HCl [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 2,5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 10 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 50 mg/g eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 10 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 2,5 % injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 100 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 2,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 1% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 4 mg + phenylephrinhydrochlorid 20 mg + phenyltoloxamincitrat 50 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + phenylephrinhydrochlorid + phenyltoloxamincitrat 2,5 mg/5 ml 5 mg/5 ml 7,5 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
paracetamol 500 mg + chlorpheniraminmaleat 8 mg + phenylephrinhydrochlorid 40 mg kapselformet tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 2 mg + hydrocodonbitartrat 2,5 mg + phenylephrinhydrochlorid 5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 1,25 mg + sulfacetamidnatrium 150 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid + sulfacetamidnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride + phenylephrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + phenylephrinhydrochlorid + phenyltoloxamincitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
acetaminophen+ chlorpheniraminmaleat + phenylephrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + hydrocodonbitartrat + phenylephrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 1 % (10 mg/ml) injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 1 % (10 mg/ml) injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid 1 % (10 mg/ml) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Phenylephrine hydrochloride 10% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 50 mg/g eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 50 mg/g eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 2.5% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 2.5% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
lidocain + phenylephrin 5 %/0,5 % spray til topikal anvendelse, opløsning |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
lidocain + phenylephrin 5 %/0,5 % spray til topikal anvendelse, opløsning |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 100 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 100 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg/mL nasal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg/mL nasal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 25 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 25 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Phenylephrine (as phenylephrine hydrochloride) 50 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
3 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride |
Inferred relationship |
Some |
1 |